This session provides an opportunity to hear from Professor Mark Strachan (Consultant Physician in Endocrinology, Western General Hospital, Edinburgh), who explored the possible complications associated with long-term steroid use. Dr Robert Stevenson and Richard Gledhill (Prostate Cancer Nurse Specialist, University Hospitals Birmingham NHS Foundation Trust) then highlight key practical considerations for the use of long-term steroids, including how to identify risk factors for steroid-related complications and how to manage patients with comorbidities (e.g. diabetes).
Following the presentations, Dr Robert Stevenson and Professor Mark Strachan engaged in an audience Q&A session.
Consultant Clinical Oncologist
Dr Rob Stevenson is a Consultant Clinical Oncologist at Queen Elizabeth Hospital, University Hospitals Birmingham (UHB) NHS Foundation Trust. He is involved in the management of patients with urological and thoracic malignancies, and is also the current radiotherapy service lead at UHB.
Dr Stevenson is experienced in 4-dimensional and stereotactic radiotherapy, and has experience in delivering CyberKnife treatment to early-stage lung cancer, and brachytherapy for prostate cancer.
He has published in peer-reviewed journals and is the principal investigator for a number of national clinical trials.
Prostate Cancer Nurse Specialist
Richard Gledhill has worked as a Prostate Cancer Nurse Specialist lead at University Hospitals Birmingham since 2003, when he was appointed as one of four nurses funded by The Prostate Cancer Charity (now known as Prostate Cancer UK). Richard manages patients at all stages of their cancer journey, but has a particular interest in patients with early relapse. Richard is one of only a handful of nurses in the UK to lead a cancer multidisciplinary team (MDT), having taken on the role of urology cancer MDT lead in 2012 and presented on the topic at the International Meeting of the European Association of Urology Nurses.
Consultant Physician in Endocrinology
Professor Mark Strachan is a Consultant Physician in Endocrinology, Diabetes and Acute Medicine at the Western General Hospital, Edinburgh, and an honorary professor at the University of Edinburgh. His main clinical interests are in endocrine oncology and pituitary disease, and his major research interest is cognitive impairment in Type 2 diabetes; he is one of the principal investigators of the Edinburgh Type 2 Diabetes Study.
He has published more than 100 original articles and book chapters, is an editor of the international medical textbook ‘Davidson’s Principles and Practice of Medicine’, editor of the award-winning book ‘Davidson’s 100 Clinical Cases’ and has also co-authored a pocket book on insulin.
Professor Strachan is Secretary of the Royal College of Physicians of Edinburgh, a member of the National Cancer Research Institute Thyroid Cancer Research Committee, a former council member of the Scottish Intercollegiate Guidelines Network and a clinical expert adviser on thyroid cancer therapies for the Scottish Medicines Consortium. He has been a trustee of the British Thyroid Foundation since 2009 and was appointed Treasurer in 2014. He is also a co-founder and trustee of the Ann Edgar Charitable Trust, which provides help and support to patients with neuroendocrine tumours and their carers.
This promotional meeting was fully funded and organised by Astellas Pharma Ltd and Astellas products may be discussed. This on-demand webinar is intended for HCPs only.
Date of preparation: February 2020 | ONC_2020_0028_UK